Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial-Reference-Cited by-同舟云学术

Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial

Published:2006-03 Issue:3 Volume:17 Page:467-472
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Camps C.,Massuti B.,Jiménez A.,Maestu I.,Gómez R. García,Isla D.,González J.L.,Almenar D.,Blasco A.,Rosell R.,Carrato A.,Viñolas N.,Batista N.,Girón C. García,Galán A.,López M.,Blanco R.,Provencio M.,Diz P.,Felip E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/3/467/341716/mdj115.pdf

Reference18 articles.

1. Cancer burden for the year 2000: the global picture;Parkin;Eur J Cancer,2001

2. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials;Non-Small Cell Lung Cancer Collaborative Group;Br Med J,1995

3. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non–small-cell lung cancer previously treated with platinum-containing chemotherapy regimens;Fossella;J Clin Oncol,2000

4. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy;Shepherd;J Clin Oncol,2000

5. Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer;Hainsworth;J Clin Oncol,1998

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Higher Docetaxel Clearance in Prostate Cancer Patients Explained by Higher CYP3A? An In Vivo Phenotyping Study with Midazolam;The Journal of Clinical Pharmacology;2023-10-26

2. Transforming approaches to treating TRK fusion cancer: historical comparison of larotrectinib and histology-specific therapies;Current Medical Research and Opinion;2020-11-28

3. Metronomic chemotherapy in non‑small cell lung cancer (Review);Oncology Letters;2020-09-29

4. Comparison of a Concurrent Fluorouracil-Based Regimen and a Taxane-Based Regimen Combined with Radiotherapy in Elderly Patients with Esophageal Squamous Cell Carcinoma;Translational Oncology;2020-03

5. Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancer;South Asian Journal of Cancer;2020-01